{"id":"condoliase","rwe":[{"pmid":"41896329","year":"2026","title":"The effectiveness of chemonucleolysis with condoliase for lumbar disc herniation in elderly patients over 70 years old.","finding":"","journal":"Neurosurgical review","studyType":"Clinical Study"},{"pmid":"41873258","year":"2026","title":"Clinical Outcomes of Intradiscal Condoliase Injection for Lumbar Disc Herniation: A Retrospective Analysis of the First 100 Cases.","finding":"","journal":"Cureus","studyType":"Clinical Study"},{"pmid":"41791966","year":"2026","title":"Impact of symptom duration on the effectiveness of intradiscal condoliase injection for lumbar disc herniation: A multicenter retrospective study.","finding":"","journal":"Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association","studyType":"Clinical Study"},{"pmid":"41695897","year":"2026","title":"Efficacy of Chemonucleolysis with Condoliase for Lumbar Disc Herniation in Elderly Patients Over 70 Years of Age.","finding":"","journal":"Spine surgery and related research","studyType":"Clinical Study"},{"pmid":"41421858","year":"2025","title":"Disc Level-Specific outcomes of intradiscal condoliase injection for lumbar disc herniation: A multicenter retrospective study.","finding":"","journal":"Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association","studyType":"Clinical Study"}],"tags":[{"label":"Biologic","category":"modality"},{"label":"Active","category":"status"},{"label":"Disorder of lumbar disc","category":"indication"},{"label":"Seikagaku Corporation","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Seikagaku Corporation","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CONDOLIASE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:05:23.165529+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:05:29.218055+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CONDOLIASE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:05:29.574593+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Hyaluronic acid hydrolytic enzyme","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:05:30.628949+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107876/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:05:30.283073+00:00"}},"allNames":["condoliase"],"offLabel":[],"synonyms":["condoliase"],"timeline":[{"date":"2018-03-23","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Seikagaku Corporation)"}],"approvals":[{"date":"2018-03-23","orphan":false,"company":"Seikagaku Corporation","regulator":"PMDA"}],"ecosystem":[{"indication":"Disorder of lumbar disc","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Biologic","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action of CONDOLIASE is unknown, but it is believed to involve interaction with a specific molecular target to modulate its activity, potentially leading to therapeutic effects in the treatment of lumbar disc disorders."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5310","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CONDOLIASE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CONDOLIASE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:17:30.106098","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:05:31.850553+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"condoliase","indications":{"approved":[{"name":"Disorder of lumbar disc","source":"DrugCentral","snomedId":443700006,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03607838","phase":"PHASE3","title":"SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)","status":"COMPLETED","sponsor":"Seikagaku Corporation","startDate":"2018-11-07","conditions":["Lumbar Disc Herniation"],"enrollment":352,"completionDate":"2023-03-21"},{"nctId":"NCT01941563","phase":"PHASE3","title":"A Study of SI-6603 in Patients With Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Seikagaku Corporation","startDate":"2013-09","conditions":["Intervertebral Disc Disease","Lumbar Disc Disease"],"enrollment":385,"completionDate":"2017-08"},{"nctId":"NCT02421601","phase":"PHASE3","title":"A Study of SI-6603 in Patients With Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Seikagaku Corporation","startDate":"2015-03","conditions":["Intervertebral Disc Disease","Lumbar Disc Disease"],"enrollment":1011,"completionDate":"2018-02"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7SI2UZG934","INN_ID":"9218","RXNORM":"1546420","UMLSCUI":"C3273430","chemblId":"CHEMBL2107876","ChEMBL_ID":"CHEMBL2107876","KEGG_DRUG":"D09800","DRUGBANK_ID":"DB12793"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Seikagaku Corporation","relationship":"Current Owner"}],"publicationCount":66,"therapeuticAreas":["Pain"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 28","pmid":"41896329","title":"The effectiveness of chemonucleolysis with condoliase for lumbar disc herniation in elderly patients over 70 years old.","journal":"Neurosurgical review"},{"date":"2026 Feb","pmid":"41873258","title":"Clinical Outcomes of Intradiscal Condoliase Injection for Lumbar Disc Herniation: A Retrospective Analysis of the First 100 Cases.","journal":"Cureus"},{"date":"2026 Mar 5","pmid":"41791966","title":"Impact of symptom duration on the effectiveness of intradiscal condoliase injection for lumbar disc herniation: A multicenter retrospective study.","journal":"Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association"},{"date":"2026 Jan 27","pmid":"41695897","title":"Efficacy of Chemonucleolysis with Condoliase for Lumbar Disc Herniation in Elderly Patients Over 70 Years of Age.","journal":"Spine surgery and related research"},{"date":"2025 Dec 19","pmid":"41421858","title":"Disc Level-Specific outcomes of intradiscal condoliase injection for lumbar disc herniation: A multicenter retrospective study.","journal":"Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"CONDOLIASE","companyName":"Seikagaku Corporation","companyId":"seikagaku-corporation","modality":"Enzyme","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2018-03-23T00:00:00.000Z","mah":"Seikagaku Corporation","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:05:31.850553+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}